Grant Support

IITRI offers drug development grant and subcontract support for startups, biotechnology companies, and academic researchers. Past funded grants include SBIR, STTR, R01, R21, and other federal and non-federal applications for efficacy studies, safety, and IND-enabling toxicology funding. All IITRI studies are performed in the United States (Chicago, IL) in case of any restrictions for subcontractor locations by funding agencies.

We have a long history of supporting work for agencies in HHS like NIH (NCI, NIAID, NIDA, NCATS), ASPR (BARDA), CDC, DOD (JPEO-CBRND), USDA, EPA, and non-profits (CARB-X, Gates Foundation). IITRI is also part of the NIH Blueprint Neurotherapeutics Network (BPN), RRPV and MCDC, and NCI IDIQs.

We are happy to provide documentation for grant submissions, and can provide counsel to early phase researchers on the appropriate preclinical toxicology studies required to fulfill FDA requirements for IND submissions. 

Documentation and assistance that IITRI may provide for grants and subcontracts:*

• Verification of our certifications, accreditations and licensure
• Documents supporting our capabilities and facilities
• Biosketches
• Study design review
• Budgetary estimates/quotations and formal proposals
• Letters of support or intent (LOS, LOI)
• Interinstitutional Assurance (IIA)
• Assistance with documentation for OLAW and ACURO approval

Working with IITRI

1. Contact us to discuss your drug candidate, preclinical goals, and grant requirements
2. We will provide supporting documentation for your grant submission*
3. Let us know when you expect to be notified of your funding status

*Note: please allow 2 weeks for us to complete your request.